1. Clinical & Scientific Overview
Adrenaline (Epinephrine) Tartrate IP [Supplementary Emergency Module App-B.1] (TIP-MED-000446, Reference Code [12.34]-CMP176) is classified under
Vaccines, Immunologicals & Emergency Toxicology Antidotes (Ch 12) as a Equine Hyperimmune F(ab')2 Immunoglobulin Antivenom against India's 'Big Four' Venomous Snakes.
Within the Indian regulatory and compendial framework, it is governed under Schedule H Prescription Drug (To be sold by retail on the prescription of a Registered Medical Practitioner only — Drugs Rules 1945).
Co-indexed per approved Author Decision DEC-01 (Option 1A; preserved in IP_Supplementary_Emergency_Module_App_B_1.json [App-B.1]). Mandatory pre-drawn 0.5 mg IM Adrenaline 1:1000 bedside protocol prior to Polyvalent ASV infusion.
Standard approved strengths (refer to comparative context)
3. Mechanism of Action & Pharmacodynamics
Co-indexed per approved Author Decision DEC-01 (Option 1A; preserved in IP_Supplementary_Emergency_Module_App_B_1.json [App-B.1]). Mandatory pre-drawn 0.5 mg IM Adrenaline 1:1000 bedside protocol prior to Polyvalent ASV infusion.
4. Therapeutic Indications & Evidence-Supported Uses
- Systemic envenomation by any of the Indian 'Big Four' venomous snakes: (1) Spectacled Cobra (Naja naja), (2) Common Krait (Bungarus caeruleus), (3) Russell's Viper (Daboia russelii), and (4) Saw-Scaled Viper (Echis carinatus)
🇮🇳 Jurisdiction & Indication Note: Indications and schedules reflect Indian compendial and regulatory records (CDSCO / Indian Pharmacopoeia & NFI / NLEM 2022). Where international reference labels (US FDA DailyMed / NCBI StatPearls) are cited for pharmacokinetic or mechanistic parameters, international approvals do not automatically imply CDSCO approval in India.
5. Educational Dosage Context, Formulations & Administration
Educational Dosing & Regimen Summary: Co-indexed per approved Author Decision DEC-01 (Option 1A; preserved in IP_Supplementary_Emergency_Module_App_B_1.json [App-B.1]). Mandatory pre-drawn 0.5 mg IM Adrenaline 1:1000 bedside protocol prior to Polyvalent ASV infusion.
Administration & Meal Timing: See Administration & Counselling below. | Standard clinical schedule per indication.
6. Pharmacokinetics, Metabolism & Renal/Hepatic Adjustment
Comparative pharmacokinetic profile co-indexed under [12.34].
Renal: Full ASV dose is mandatory to arrest Russell's viper venom-induced acute kidney injury and DIC. • Hepatic: No adjustment.
Renal: Full ASV dose is mandatory to arrest Russell's viper venom-induced acute kidney injury and DIC. • Hepatic: No adjustment.
Renal: Full ASV dose is mandatory to arrest Russell's viper venom-induced acute kidney injury and DIC. • Hepatic: No adjustment.
7. Contraindications, Precautions & High-Risk Warnings
- Contraindications: No absolute contraindications in systemic snakebite envenomation! DO NOT perform intradermal or conjunctival ASV sensitivity skin tests (MoHFW guidelines state skin tests have zero predictive value for non-IgE anaphylactoid reactions and dangerously delay life-saving therapy). • Precautions: Early anaphylactoid/pyrogenic reactions occur in 20–50% of patients within 10–60 minutes: keep ADRENALINE (1:1000, 0.5 mg IM into anterolateral thigh) drawn up in a syringe at the bedside before starting ASV! If a reaction occurs, temporarily stop ASV, give IM Adrenaline + IV Chlorpheniramine + IV Hydrocortisone, and restart ASV slowly once BP/bronchospasm stabilises.
Key Clinical Precautions: Renal: Full ASV dose is mandatory to arrest Russell's viper venom-induced acute kidney injury and DIC. • Hepatic: No adjustment.
8. Adverse Effects Profile
- Early anaphylactoid reaction (urticaria, pruritus, rigor/chills, fever, nausea, tachycardia), late serum sickness (fever, arthralgia, lymphadenopathy 5–14 days later).
- Severe bronchospasm, angioedema, hypotensive anaphylactic shock.
9. Major Drug–Drug, Drug–Food & Drug–Herb Interactions
- Combine with Neostigmine (1
- 5 mg IV/IM + Atropine 0
- 6 mg) in neurotoxic Cobra bites (postsynaptic alpha-neurotoxin); pre-synaptic Krait beta-bungarotoxin responds poorly to Neostigmine and requires early mechanical ventilation
10. Clinical Monitoring, Patient Counselling & Storage
Clinical & Laboratory Monitoring: Monitor clinical parameters per parent class monograph [12.34].
Pharmacist Patient Counselling Points:
- Patient Counselling Checklist: Reassure patient/family that pressure-immobilisation, tourniquets, incision, suction, or herbal stones must be avoided; report delayed fever or joint pain 1-2 weeks after discharge (serum sickness).
- Meal & Clock Timing Instruction: See Administration & Counselling below. (Standard clinical schedule per indication.)
- Missed Dose Protocol: Take as soon as remembered unless close to next scheduled dose; never double the dose.
- Geriatric Dispensing Pearl: Schedule: Schedule H | NLEM 2022: Yes | Compendia: IP 2026 / NFI 7th Ed 2026 / NLEM 2022 / MoHFW National Snakebite Treatment Protocol
Storage, Stability & Dispensing Safeguards: COLD CHAIN MANDATORY (2°C–8°C): Store in a pharmaceutical refrigerator between 2°C and 8°C; DO NOT FREEZE. Protect from light and heat during dispensing.
11. Visual Pharmacology & Mechanism Diagram (svg-v339-01-adme-12-step-journey)
12. Authoritative References, Regulatory Sources & Editorial Disclaimer
Primary Compendial & Guideline Reference: Indian Pharmacopoeia (IP 2022) • NFI • CDSCO
Official Verification Portals: Indian Pharmacopoeia Commission (IPC) & National Formulary of India (NFI) • Central Drugs Standard Control Organization (CDSCO) • Ministry of Health & Family Welfare — NLEM 2022 • NCBI Bookshelf / StatPearls Pharmacology Reference • DailyMed (US FDA Official Prescribing Reference)
Last Medically & Pharmaceutically Reviewed: 2026-11-10 • Verification Status: VERIFIED_EDUCATIONAL_CONTENT
Educational & Clinical Disclaimer: This reference profile is published solely for pharmacy education, academic study, and professional clinical reference. It does not substitute for patient-specific clinical judgement, qualified specialist oncology/medical supervision, or official CDSCO/IP prescribing information. Never self-medicate with prescription, Schedule H/H1/X, NDPS, or oncology medicines.
13. Related Reference Monographs, Educational Guides & Visual Concept
💊 Related Pharmacological / Category Profiles
- [12.36]-C179 Diphtheria Toxoid (Td) — Adsorbed Bacterial Toxoid Vaccine (Active Immunisation against Cl
- [12.36]-C180 Adsorbed Tetanus Toxoid (TT) — Adsorbed Bacterial Toxoid Vaccine (Active Immunisation against Cl
- [12.31] Naloxone Hydrochloride (Parenteral Opioid Overdose Antidote) — Pure Competitive Opioid Receptor Antagonist (Mu, Kappa & Delta An
- [12.32] Atropine Sulphate (Parenteral Bradycardia & OP Poisoning Antidote) — Competitive Muscarinic Acetylcholine Receptor Antagonist (Anticho
/medicine/12-32-cmp175-adrenaline-epinephrine-tartrate-ip-supplementary-eme/ for complementary therapeutic comparison and dosing context.